Autolus Therapeutics plc AUTL on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001730463
0001730463
EIN:
LEI:
(CF Office: 03 Life Sciences)
Business address:
THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
Phone: 44 20 3829 6230
THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
Phone: 44 20 3829 6230
Mailing address:
THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- Autolus Therapeutics Ltd - filings through 2018-06-08
Filings:
239 EDGAR filings since February 9, 2018
239 EDGAR filings since February 9, 2018
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- April 23, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- April 4, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- April 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- March 21, 2025 - EFFECT: Notice of Effectiveness Open documentClick to Open document FilingOpen filingClick to Open filing
- March 20, 2025 - POS AM: Post-Effective amendments for registration statement Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- April 23, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- April 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- March 20, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- January 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 20, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 12, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 8, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 17, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 13, 2024 - NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
No insider transaction filings for this company in last 365 days
- Beneficial ownership (Schedule 13D and 13G)
- April 4, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 239 entries
Data source:
CIK0001730463.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
